Medication Safety - Advanced Lab Panel
The Medication Safety Advanced Lab Panel provides a deeper safety review for people taking prescription or over-the-counter medications. It evaluates liver function, kidney filtration, urine health, muscle enzymes, pancreatic enzymes, blood sugar, cholesterol, inflammation, iron status, magnesium, vitamin D, uric acid, and cardiovascular risk markers. This panel includes CBC, CMP, cystatin C, GGT, bilirubin, PT/INR, CK, lipase, amylase, A1c, lipids, ApoB, Lp(a), and urinalysis.
- $2,387.97
- $436
- Save: 81.74%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Microalbumin Random Urine with Creatinine
Creatinine, Random Urine
Microalbumin
Microalbumin/Creatinine
Amylase
Apolipoprotein B
Also known as: Bilirubin Fractionated
Bilirubin, Direct
Bilirubin, Indirect
Bilirubin, Total
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils (Only Reported If Detected)
Absolute Basophils
Absolute Blasts (Only Reported If Detected)
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes (Only Reported If Detected)
Absolute Monocytes
Absolute Myelocytes (Only Reported If Detected)
Absolute Neutrophils
Absolute Nucleated Rbc (Only Reported If Detected)
Absolute Promyelocytes (Only Reported If Detected)
Band Neutrophils (Only Reported If Detected)
Basophils
Blasts (Only Reported If Detected)
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes (Only Reported If Detected)
Monocytes
MPV
Myelocytes (Only Reported If Detected)
Neutrophils
Nucleated Rbc (Only Reported If Detected)
Platelet Count
Promyelocytes (Only Reported If Detected)
RDW
Reactive Lymphocytes (Only Reported If Detected)
Red Blood Cell Count
White Blood Cell Count
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
Also known as: CK (Total), CPK, CPK (Total), Creatine Kinase CK Total, Creatine Phosphokinase (CPK), Total CK
Creatine Kinase, Total
CYSTATIN C
eGFR
Ferritin
Also known as: Gamma Glutamyl Transferase GGT, Gamma-Glutamyl Transferase, Gamma-Glutamyl Transpeptidase, Gamma-GT, GGTP, GTP
Ggt
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
HEMOGLOBIN A1C
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Hs Crp
Also known as: Iron and TIBC, Iron and Total Iron Binding Capacity TIBC, TIBC
% Saturation
Iron Binding Capacity
Iron, Total
Also known as: LPS
Lipase
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
Non HDL Cholesterol
Triglycerides
Also known as: Lipoprotein A, Lp (a), Lp(a)
Lipoprotein (A)
Magnesium
Also known as: Pro Time with INR, Prothrombin Time and International Normalized Ratio, Prothrombin Time PT with INR, Prothrombin Time with INR, Protime with INR, PT
Inr
Pt
Vitamin D, 25-Oh, D2
Vitamin D, 25-Oh, D3
Vitamin D, 25-Oh, Total
Also known as: Serum Urate, UA
Uric Acid
Also known as: UA, Complete, Urinalysis UA Complete, Urine Analysis, Complete
Amorphous Sediment (Only Reported If Detected)
Appearance
Bacteria
Bilirubin
Calcium Oxalate Crystals (Only Reported If Detected)
Casts (Only Reported If Detected)
Color
Crystals (Only Reported If Detected)
Glucose
Granular Cast (Only Reported If Detected)
Hyaline Cast
Ketones
Leukocyte Esterase
Nitrite
Occult Blood
Ph
Protein
Rbc
Reducing Substances (Only Reported If Detected)
Renal Epithelial Cells (Only Reported If Detected)
Specific Gravity
Squamous Epithelial Cells
Transitional Epithelial (Only Reported If Detected)
Triple Phosphate Crystals (Only Reported If Detected)
Uric Acid Crystals (Only Reported If Detected)
WBC
YEAST (Only Reported If Detected)
Also known as: Cobalamin, Folic Acid, Vitamin B 12, Vitamin B 12 and Folic Acid, Vitamin B12 Cobalamin and Folate Panel Serum, Vitamin B12/Folic Acid
Folate, Serum
Vitamin B12
The Medication Safety - Advanced Lab Panel panel contains 22 tests with 116 biomarkers .
The Medication Safety Advanced Lab Panel is designed for people who want a deeper lab-based review while taking prescription medications, over-the-counter medications, or long-term therapies that may affect the liver, kidneys, muscles, pancreas, blood counts, blood sugar, cholesterol, inflammation, or nutrient status.
Many medications are processed by the liver, cleared by the kidneys, or can influence blood counts, muscle enzymes, glucose, lipids, uric acid, or inflammation. This panel brings together a broad set of safety markers that may help support a physician-guided medication review.
This panel does not prove that a medication is safe or unsafe by itself. Results should be interpreted with a licensed healthcare provider and reviewed alongside your medication list, dose, duration of use, symptoms, medical history, alcohol use, supplement use, and overall health goals.
Why Order This Panel?
The Medication Safety Advanced Lab Panel may be helpful for people who take one or more medications and want a deeper look at key safety-related biomarkers.
This panel may help provide insight into:
- Blood count and platelet patterns
- Liver enzymes, bile flow, bilirubin, and clotting-related liver function
- Kidney filtration and urine albumin patterns
- Urinalysis findings such as protein, blood, glucose, or ketones
- Muscle enzyme activity related to statins, exercise, or muscle symptoms
- Pancreatic enzyme activity related to abdominal symptoms or medication effects
- Blood sugar and A1c patterns
- Cholesterol, ApoB, and Lipoprotein(a)
- Low-grade inflammation
- Iron storage and iron availability
- Magnesium and vitamin D status
- Uric acid patterns related to gout, kidney stones, diuretics, or metabolic health
This Panel May Be Helpful For People Who Use
- Statins or cholesterol-lowering medications
- Blood pressure medications or diuretics
- Diabetes or metabolic medications
- GLP-1 medications
- Anti-inflammatory medications
- Long-term over-the-counter medications
- Medications that may affect liver or kidney function
- Medications associated with muscle symptoms
- Medications that may affect glucose, cholesterol, uric acid, or nutrient status
- Multiple medications at the same time
Common Symptoms or Situations This Panel May Help Evaluate
This panel may be useful for people with or concerned about:
- Fatigue or low energy
- Muscle aches, weakness, or cramps
- Abdominal discomfort or pancreatic enzyme concerns
- Abnormal liver enzymes
- Kidney function concerns
- Blood sugar or A1c concerns
- High cholesterol or triglycerides
- Gout or high uric acid concerns
- Medication changes
- Long-term medication use
- Statin use with muscle symptoms
- Diuretic use
- Desire for a deeper medication safety baseline
What This Panel Helps Evaluate
This panel helps evaluate selected biomarkers related to:
- Blood count and general safety markers
- Liver function, bile flow, bilirubin, and clotting context
- Kidney filtration and urine health
- Urine albumin patterns
- Muscle enzyme activity
- Pancreatic enzyme activity
- Blood sugar and A1c
- Cholesterol and advanced lipid risk
- Inflammation
- Iron storage and iron availability
- Magnesium status
- Vitamin D status
- Uric acid
- General medication safety review
Tests Included and Why They Matter
Blood Health & General Medication Safety
This group helps evaluate blood count patterns that may be relevant when reviewing medication safety. Some medications may affect red blood cells, white blood cells, platelets, inflammation patterns, or overall blood health.
CBC, includes Differential and Platelets
The CBC evaluates red blood cells, white blood cells, hemoglobin, hematocrit, platelets, and different types of white blood cells.
This test is included because medication safety review often benefits from a broad blood count baseline. CBC results may provide context for anemia, infection clues, immune activity, platelet changes, inflammation, fatigue, bruising, or general wellness patterns.
CBC is especially useful when reviewing medications that may affect blood counts, immune response, bleeding risk, fatigue, or inflammatory patterns.
Liver Function, Bile Flow & Clotting Safety
The liver plays a major role in processing many medications. This group helps evaluate liver enzymes, bile flow, bilirubin processing, and clotting-related liver function.
Comprehensive Metabolic Panel, CMP
The CMP evaluates glucose, liver function, kidney function, electrolytes, calcium, albumin, total protein, and other metabolic markers.
This test is included because it provides the core foundation for medication safety monitoring. CMP liver markers can help evaluate liver enzyme patterns, while kidney markers and electrolytes may provide medication clearance and hydration context.
Gamma Glutamyl Transferase, GGT
GGT is a liver and bile duct enzyme.
This test is included because it may provide additional context for liver stress, bile flow, alcohol exposure, fatty liver patterns, medication use, and supplement use. GGT can be useful when CMP liver enzymes are abnormal or when a deeper liver safety review is desired.
Bilirubin, Fractionated
Bilirubin, Fractionated measures total, direct, and indirect bilirubin.
This test is included because bilirubin patterns may provide more detailed context for liver processing, bile flow, red blood cell breakdown, and bilirubin metabolism. It is more complete than direct bilirubin alone.
Prothrombin Time, PT with INR
PT/INR evaluates clotting time and may provide liver synthetic function context.
This test is included because the liver produces several clotting factors. PT/INR adds a deeper liver safety marker beyond liver enzymes alone and may be useful when reviewing medication effects, liver stress, bleeding risk, or anticoagulant-related discussions.
Kidney Filtration, Urine Health & Medication Clearance
The kidneys help clear many medications and metabolic waste products. Kidney function can influence medication dosing, medication safety, and the risk of side effects. This group helps evaluate filtration, urine findings, and early kidney stress patterns.
Cystatin C with eGFR
Cystatin C with eGFR provides an additional estimate of kidney filtration.
This test is included because cystatin C may provide kidney function context beyond creatinine alone. It can be useful when reviewing medication clearance, kidney safety, or kidney function in people whose creatinine may be affected by muscle mass, age, diet, or other factors.
Albumin, Random Urine with Creatinine
This urine test evaluates albumin relative to creatinine.
It is included because urine albumin may provide early kidney and vascular stress context. This can be especially relevant for people taking medications for blood pressure, diabetes, kidney risk, or cardiometabolic conditions.
Urinalysis, UA, Complete
A complete urinalysis evaluates urine findings such as protein, blood, glucose, ketones, specific gravity, pH, and other markers.
This test is included because urine findings may provide safety context for kidney health, hydration, glucose handling, blood or protein in urine, and urinary abnormalities. It adds practical urine-based information to the blood-based kidney markers.
Muscle, Pancreas & Medication-Related Enzyme Safety
Some medications may affect muscles or be associated with muscle symptoms. Other medications may be reviewed in the context of pancreatic enzymes or abdominal symptoms. This group adds enzyme markers that may help clarify safety patterns.
Creatine Kinase, CK, Total
CK is an enzyme found mainly in muscle tissue.
This test is included because CK may provide context for muscle injury, statin-related muscle symptoms, intense exercise, muscle inflammation, or muscle breakdown. CK can also help clarify whether elevated AST or ALT may be related to muscle rather than liver sources.
This is a valuable medication safety marker for people using statins, performance products, or medications associated with muscle aches or weakness.
Lipase
Lipase is an enzyme related to pancreatic function and fat digestion.
This test is included because lipase may provide pancreas-related context when people have abdominal symptoms or take medications where pancreatic concerns may be reviewed, including some metabolic or weight-management therapies.
Amylase
Amylase is an enzyme involved in carbohydrate digestion and is produced by the pancreas and salivary glands.
This test is included because it may provide additional pancreatic enzyme context when reviewed with lipase and symptoms. Lipase is generally more pancreas-specific, but amylase can add broader digestive enzyme context in an Advanced panel.
Blood Sugar, Cholesterol & Cardiometabolic Medication Context
Many medications can affect blood sugar, cholesterol, uric acid, and cardiovascular risk markers. This group helps evaluate cardiometabolic safety and longer-term health context.
Hemoglobin A1c
Hemoglobin A1c measures average blood sugar over approximately the past two to three months.
This test is included because blood sugar patterns may be relevant to diabetes medications, GLP-1 medications, steroid exposure, metabolic health, kidney risk, cardiovascular wellness, and medication safety review.
Lipid Panel
The Lipid Panel measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides.
This test is included because lipid patterns may be relevant to statin therapy, hormone therapy, metabolic medications, weight-management medications, and cardiovascular safety monitoring.
Apolipoprotein B
Apolipoprotein B, or ApoB, reflects the number of atherogenic cholesterol-carrying particles.
This test is included because ApoB may provide additional cardiovascular risk context beyond a standard LDL cholesterol result. It may be useful when reviewing lipid-lowering medications, metabolic risk, or cardiovascular prevention goals.
Lipoprotein(a)
Lipoprotein(a), often called Lp(a), is an inherited cholesterol-related marker.
This test is included because Lp(a) may provide cardiovascular risk context that is not captured by a standard Lipid Panel. It is often useful as a once-in-a-lifetime or periodic risk marker depending on provider guidance.
hs-CRP
High-sensitivity C-reactive protein is a marker of low-grade inflammation.
This test is included because inflammation may provide useful context for cardiometabolic risk, medication safety review, ferritin interpretation, liver/metabolic health, and general wellness monitoring.
Uric Acid
Uric acid is a metabolic waste product.
This test is included because uric acid may provide context for gout risk, kidney stone risk, diuretic use, metabolic syndrome patterns, kidney health, and medication safety. This can be especially relevant for people taking diuretics, certain blood pressure medications, or medications that affect kidney handling of uric acid.
Iron, Magnesium & Vitamin D Safety Context
Medication use, diet, inflammation, and supplements can affect nutrient and mineral patterns. This group helps evaluate iron status, magnesium status, and vitamin D status, which may be relevant to fatigue, muscle symptoms, bone health, and general medication safety.
Ferritin
Ferritin measures stored iron.
This test is included because ferritin may provide context for iron storage, iron overload, inflammation, liver/metabolic patterns, fatigue, and anemia-related concerns. Ferritin should be interpreted with iron/TIBC and inflammation markers because ferritin can rise with inflammation.
Iron and Total Iron Binding Capacity, TIBC
Iron and TIBC help evaluate circulating iron and iron transport capacity.
This test is included because iron deficiency, iron overload, or abnormal iron availability may provide useful context for fatigue, anemia, liver health, inflammation, and supplement or medication review.
Magnesium
Magnesium supports muscle function, nerve signaling, blood pressure regulation, glucose metabolism, sleep, and energy production.
This test is included because magnesium status may provide context for medication effects, diuretic use, muscle cramps, fatigue, blood pressure support, metabolic health, and supplement safety.
QuestAssureD™ 25-Hydroxyvitamin D, D2, D3, LC/MS/MS
Vitamin D testing measures vitamin D status.
This test is included because vitamin D may be relevant to bone health, immune function, muscle symptoms, inflammation, calcium balance, and general wellness. It is also useful when reviewing vitamin D supplementation or medications that may affect bone or mineral metabolism.
Related Biomarker Patterns This Panel May Help Identify
This panel may help identify or rule out lab patterns related to:
- Blood count abnormalities
- Anemia-related findings
- Liver enzyme or bile flow changes
- Bilirubin pattern changes
- Liver synthetic or clotting function changes
- Kidney filtration changes
- Urine albumin or urinalysis abnormalities
- Muscle enzyme elevation
- Pancreatic enzyme elevation
- Blood sugar imbalance
- Cholesterol and ApoB-related risk
- Lp(a)-related inherited cardiovascular risk
- Low-grade inflammation
- Uric acid elevation
- Iron deficiency or iron overload patterns
- Magnesium status
- Vitamin D status
- General medication safety concerns
Professional Safety and Interpretation Notice
This panel is designed to support medication safety review. It does not prove that a medication is safe or unsafe by itself. Results should be interpreted with a licensed healthcare provider and reviewed alongside your medication list, medication doses, medical conditions, symptoms, alcohol use, supplement use, diet, kidney function, liver function, and health goals.
Do not stop or change any prescribed medication without guidance from your healthcare provider.
Additional Panels to Consider
Customers interested in the Medication Safety Advanced Lab Panel may also consider:
- Medication & Supplement Safety Essential Lab Panel
- Medication & Supplement Safety Advanced Lab Panel
- Medication & Supplement Safety Comprehensive Lab Panel
- Supplement Safety Lab Panel
- GLP-1 Medication Safety Lab Panel
- Hormone Therapy Safety Lab Panel
- Kidney, Liver & Detox Support Lab Panel
- Heart Health & Cholesterol Lab Panel
- Vitamin, Mineral & Nutrient Deficiency Lab Panel
- Prediabetes & Insulin Resistance Lab Panel
How to Prepare for This Panel
Preparation may vary depending on the specific tests included and instructions provided with your order. In general:
- Fasting may be recommended because this panel includes glucose-related and lipid markers.
- Bring or keep a complete list of prescription medications, over-the-counter medications, supplements, vitamins, minerals, herbal products, and doses.
- Note recent alcohol intake, medication changes, muscle symptoms, abdominal symptoms, fatigue, or urinary symptoms.
- Avoid unusually intense exercise before testing if CK is included, unless your healthcare provider advises otherwise.
- Drink water normally unless instructed otherwise.
- Do not overhydrate before urine testing.
- Continue medications unless your healthcare provider tells you otherwise.
- Follow all lab collection instructions provided with your order.
What Happens After You Receive Your Results?
After your results are available, your biomarkers can help organize medication safety findings into areas such as blood health, liver function, kidney filtration, urine findings, muscle enzymes, pancreatic enzymes, blood sugar, cholesterol, inflammation, iron status, magnesium, vitamin D, uric acid, and cardiometabolic risk.
During the physician consultation, you can discuss whether your results suggest the need for follow-up testing, medication review, lifestyle changes, supplement review, or additional monitoring based on your health history and current medication use.
Frequently Asked Questions
What is the Medication Safety Advanced Lab Panel?
The Medication Safety Advanced Lab Panel is a lab panel that evaluates selected biomarkers related to liver function, kidney filtration, urine health, muscle enzymes, pancreatic enzymes, blood sugar, cholesterol, inflammation, iron status, magnesium, vitamin D, uric acid, and general medication safety.
Who may benefit from this panel?
This panel may be useful for people taking prescription medications, over-the-counter medications, statins, blood pressure medications, metabolic medications, diabetes medications, anti-inflammatory medications, or multiple medications at the same time.
Does this panel prove that my medication is safe?
No. No lab panel can prove that a medication is safe in every situation. This panel helps evaluate selected safety markers that may be useful to review with a licensed healthcare provider.
Why are liver and kidney tests included?
The liver helps process many medications, while the kidneys help clear many substances from the body. Liver and kidney markers may provide important safety context.
Why is CK included?
CK is included because muscle injury, intense exercise, statins, supplements, or muscle inflammation can raise CK and may also contribute to AST or ALT elevations that can be confused with liver-related patterns.
Why are lipase and amylase included?
Lipase and amylase are included to provide pancreas-related context, especially when medications, alcohol, metabolic therapies, or abdominal symptoms are being reviewed.
Important Note
This panel is designed to help evaluate selected biomarkers that may be related to medication safety, liver function, kidney function, muscle enzymes, pancreatic enzymes, blood sugar, cholesterol, inflammation, iron status, magnesium, vitamin D, uric acid, urine health, and cardiometabolic risk. It is not intended to diagnose, treat, cure, or prevent disease by itself. Results should be reviewed with a licensed healthcare provider.